Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study

Per-Particle Triglyceride-Rich Lipoproteins Imply Higher Myocardial Infarction Risk Than Low-Density Lipoproteins

(2021) Mia Ø. Johansen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

(2021) Camilla Ditlev Lindhardt Johannesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease

(2021) Michael G. Levin et al.   CIRCULATION

Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction

(2021) Anette Varbo et al.   EUROPEAN HEART JOURNAL

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

(2020) Maureen Sampson et al.   JAMA Cardiology

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

(2020) Edward K. Duran et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study

(2020) Mia Ø Johansen et al.   CLINICAL CHEMISTRY

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

(2020) Edward K Duran et al.   CLINICAL CHEMISTRY

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

(2020) Stephen J. Nicholls et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

(2020) Mie Balling et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease

(2020) Olga Castañer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association

(2019) Jacqueline E. Tamis-Holland et al.   CIRCULATION

Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

(2019) Anette Varbo et al.   ANNALS OF NEUROLOGY

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis

(2019) Peige Song et al.   Lancet Global Health

Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review

(2019) Rupert Bauersachs et al.   Cardiovascular Therapeutics

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence - Prospective Data from the Women's Health Study

(2018) Aaron W. Aday et al.   CIRCULATION

Advances in lipid-lowering therapy through gene-silencing technologies

(2018) Børge G. Nordestgaard et al.   Nature Reviews Cardiology

Pathology of Peripheral Artery Disease in Critical Limb Ischemia

(2018) Navneet Narula et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

(2018) Aruna D. Pradhan et al.   AMERICAN HEART JOURNAL

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

(2017) Victor Aboyans et al.   EUROPEAN HEART JOURNAL

Validity of Peripheral Arterial Disease Diagnoses in the Danish National Patient Registry

(2017) A.N. Lasota et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

(2015) A. Varbo et al.   CLINICAL CHEMISTRY

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

A toolkit for measurement error correction, with a focus on nutritional epidemiology

(2014) Ruth H. Keogh et al.   STATISTICS IN MEDICINE

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

(2013) Seth S. Martin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Proportional Hazards Regression in Epidemiologic Follow-up Studies

(2012) John Cologne et al.   EPIDEMIOLOGY

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

(2012) Anders Berg Jørgensen et al.   EUROPEAN HEART JOURNAL

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

(2009) Pia R. Kamstrup   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION